Is Phion Therapeutics Ltd in administration?
Last verified 11 July 2026
Yes, Phion Therapeutics Ltd (company number NI645613) entered administration on 23 September 2024. John Donaldson of KPMG was appointed as administrator.
Do you deal with companies like Phion Therapeutics Ltd? Add up to 5 companies free. We'll email you the day one enters administration.
Free, no card. We'll send a one-click sign-in link, no password to remember.
Prefer the earlier signs? Protect catches the pattern that builds, well before it's official. See how it works →
Phion Therapeutics Ltd is now under the control of an administrator. Below are the key dates, the directors, the public-record timeline that led here, and what the administration means if you are a creditor, employee, customer or supplier.
Company at a glance
| Status | In Administration |
|---|
| Company number | NI645613 |
|---|
| Incorporated | 8 May 2017 (9 years old) |
|---|
| Registered office | C/O Kpmg The Soloist Building, Belfast, BT1 3LP |
|---|
| Nature of business (SIC) | 82990: Other business support service activities n.e.c. |
|---|
| Date entered administration | 23 September 2024 |
|---|
| Administrator | John Donaldson, KPMG (licensed insolvency practitioner) |
|---|
| Official notice | View the official notice ↗ |
|---|
| Public register | View filing history ↗ |
|---|
About the business
Phion Therapeutics Ltd is a UK limited company based in Belfast, incorporated in 2017 and 7 years old when the administrator was appointed. Its registered activity is other business support service activities n.e.c. (SIC 82990). There have been 8 director appointments since incorporation, of which 2 were on the board when the administrator was appointed, alongside 1 person with significant control. 1 charge has been registered against the company, all of which are recorded as satisfied.
Statement of Affairs
No Statement of Affairs is on record for this company. The 75-day filing window has passed without a Statement of Affairs being filed.
Directors
8 people have been appointed as directors of Phion Therapeutics Ltd.
DirectorStatusAppointedResigned
A director resignation shortly before an insolvency is a matter of public record; it does not by itself imply wrongdoing.
Persons with significant control
Individuals or entities with significant influence or control.
Invox Pharma Limited
corporate entity person with significant control
Ownership of shares 50-75%Voting rights 50-75%
3 ceased controls
- Qubis Ltd · ceased 3 Oct 2017
- Mr David Alan Tabaczynski · ceased 24 Jun 2021
- Professor Helen Olga Mccarthy · ceased 24 Jun 2021
Charges register
Secured creditors and encumbrances against the company. 0 outstanding · 1 satisfied.
Status · Creditor · Type · Dates
SatisfiedInnovate UK Loans Limited
A registered charge · Created 30 May 2019 · Satisfied 11 Sep 2025
What happened
EventDateType
Administrator's progress report22 April 20262.24B(NI)
Notice of extension of period of Administration20 March 20262.31B(NI)
Administrator's progress report to 2025-09-2216 October 20252.24B(NI)
Notice of extension of period of Administration19 September 20252.31B(NI)
Satisfaction of charge NI6456130001 in full11 September 2025MR04 +63 earlier events · 2017 to 2025
Administrator's progress report to 2025-03-2228 April 20252.24B(NI)
Statement of affairs20 December 20242.16B(NI)
Notice of result of meeting of creditors10 December 20242.23B(NI)
Statement of administrator's proposal15 November 20242.17B(NI)
Registered office address changed from 63 University Road, Research and Enterprise Belfast, Antrim BT7 1NF Northern Ireland to C/O Kpmg the Soloist Building 1 Lanyon Place Belfast BT1 3LP on 2024-10-022 October 2024AD01 Appointment of an administrator25 September 20242.12B(NI)
AdministrationStatus23 September 2024
Termination of appointment of George Orphanides as a director on 2024-09-1316 September 2024TM01 Confirmation statement made on 2024-05-07 with updates17 May 2024CS01 Termination of appointment of Helen Mccarthy as a director on 2024-01-266 February 2024TM01 Termination of appointment of David Moore as a director on 2023-06-013 July 2023TM01 Termination of appointment of Darach Neeson as a director on 2023-06-013 July 2023TM01 Statement of capital following an allotment of shares on 2023-06-0119 June 2023SH01 Memorandum and Articles of Association15 June 2023MA Confirmation statement made on 2023-05-07 with updates25 May 2023CS01 Accounts for a small company made up to 2021-12-3117 May 2023AA Statement of capital following an allotment of shares on 2022-12-012 March 2023SH01 Compulsory strike-off action has been discontinued27 July 2022DISS40 First Gazette notice for compulsory strike-off26 July 2022GAZ1 Confirmation statement made on 2022-05-07 with updates22 July 2022CS01 Change of details for Invox Pharma Limited as a person with significant control on 2021-06-2422 July 2022PSC05 Appointment of Dr George Orphanides as a director on 2022-02-0122 June 2022AP01 Total exemption full accounts made up to 2021-05-312 March 2022AA Current accounting period shortened from 2022-05-31 to 2021-12-3120 December 2021AA01 Director's details changed for Mr Benjamin Toogood on 2021-08-164 September 2021CH01 Appointment of Mr Benjamin Toogood as a director on 2021-06-2420 July 2021AP01 Notification of Invox Pharma Limited as a person with significant control on 2021-06-2420 July 2021PSC02 Cessation of Helen Mccarthy as a person with significant control on 2021-06-2420 July 2021PSC07 Cessation of David Alan Tabaczynski as a person with significant control on 2021-06-2420 July 2021PSC07 Statement of capital following an allotment of shares on 2021-06-246 July 2021SH01 Statement of capital following an allotment of shares on 2021-06-246 July 2021SH01 Change of share class name or designation6 July 2021SH08 Memorandum and Articles of Association6 July 2021MA Statement of capital following an allotment of shares on 2021-06-245 July 2021SH01 Confirmation statement made on 2021-05-07 with no updates17 May 2021CS01 Total exemption full accounts made up to 2020-05-3111 March 2021AA Memorandum and Articles of Association6 July 2020MA Memorandum and Articles of Association24 June 2020MA Confirmation statement made on 2020-05-07 with updates20 May 2020CS01 Change of details for Professor Helen Mccarthy as a person with significant control on 2019-08-0120 May 2020PSC04 Termination of appointment of David Tabaczynski as a director on 2020-03-0217 May 2020TM01 Sub-division of shares on 2019-10-152 March 2020SH02 Total exemption full accounts made up to 2019-05-312 March 2020AA Director's details changed for Prof Helen Mccarthy on 2019-08-0127 October 2019CH01 Director's details changed for Mr Darach Neeson on 2019-07-2527 October 2019CH01 Appointment of Dr John Stephen Fox as a director on 2019-08-0112 September 2019AP01 Registration of charge NI6456130001, created on 2019-05-303 June 2019MR01 Confirmation statement made on 2019-05-07 with no updates21 May 2019CS01 Notification of David Alan Tabaczynski as a person with significant control on 2017-10-0317 May 2019PSC01 Appointment of Mr David Moore as a director on 2019-01-3018 April 2019AP01 Total exemption full accounts made up to 2018-05-3112 February 2019AA Confirmation statement made on 2018-05-07 with updates21 May 2018CS01 Cessation of Qubis Ltd as a person with significant control on 2017-10-0321 May 2018PSC07 Notification of Helen Mccarthy as a person with significant control on 2017-10-0321 May 2018PSC01 Statement of capital following an allotment of shares on 2017-10-0321 May 2018SH01 Appointment of Mr David Tabaczynski as a director on 2017-10-033 October 2017AP01 Appointment of Prof Helen Mccarthy as a director on 2017-10-033 October 2017AP01 Termination of appointment of Qubis Ltd as a director on 2017-10-033 October 2017TM01 What this means for you
If you are a creditor
Contact the administrator (KPMG) to register your claim. You cannot start or continue legal action against the company without the court's or administrator's permission. Unsecured creditors are typically paid last.
A creditor's checklist →If you are an employee
Employees are preferential creditors for certain unpaid wages and holiday pay, and may be able to claim from the Redundancy Payments Service if roles are made redundant.
Employee rights and redundancy pay →If you are a customer
Orders, deposits and warranties may be affected. Deposits paid are usually unsecured claims. Contact the administrator about outstanding work or refunds.
What customers can recover →If you are a supplier
Goods supplied before the appointment are an unsecured claim. Check whether any retention-of-title clause applies to goods you can identify and recover.
How retention of title works →Don't be the last to know next time
Most suppliers only find out a customer has failed once it is announced. By then it is too late. Protect monitors every company you sell to and emails you as the warning signs build, well before it becomes official. We can't stop a customer failing, but you'll never be the last to know, and you'll know you did all you could.
See how Protect works, £24/mo →Other companies in administration
Related guides
The bigger picture
Frequently asked questions
- Is Phion Therapeutics Ltd in administration?
- Yes. Phion Therapeutics Ltd (company number NI645613) entered administration on 23 September 2024. John Donaldson of KPMG was appointed as administrator.
- Who is the administrator of Phion Therapeutics Ltd?
- John Donaldson, a licensed insolvency practitioner at KPMG, was appointed administrator of Phion Therapeutics Ltd on 23 September 2024. Creditors can contact the administrator directly to submit a claim.
- What does Phion Therapeutics Ltd do?
- Phion Therapeutics Ltd's registered nature of business is other business support service activities n.e.c. (SIC 82990).
- Where is Phion Therapeutics Ltd based?
- Phion Therapeutics Ltd's registered office is C/O Kpmg The Soloist Building, Belfast, BT1 3LP. The registered office is the address held on the public register, which is not always the trading address.
- When was Phion Therapeutics Ltd founded?
- Phion Therapeutics Ltd was incorporated on 8 May 2017, 7 years before the administrator was appointed.
- What is Phion Therapeutics Ltd's company number?
- Phion Therapeutics Ltd's registered company number is NI645613.
- Who has significant control of Phion Therapeutics Ltd?
- 1 active person with significant control over Phion Therapeutics Ltd is on the register: Invox Pharma Limited.
- Are jobs at Phion Therapeutics Ltd at risk?
- When a company enters administration the administrator decides whether to continue trading, sell the business as a going concern, or wind it down. Employees can contact the administrator (KPMG) for any update on their role, and may be able to claim from the Redundancy Payments Service if their job is made redundant.
- What does administration mean for creditors of Phion Therapeutics Ltd?
- Administration is a formal insolvency process that gives a company protection from creditors while an administrator tries to rescue it or achieve a better result than liquidation. Creditors cannot start or continue legal action without permission. Unsecured creditors are usually paid last, often only a portion of what they are owed, if anything.
- When did Phion Therapeutics Ltd go into administration?
- Phion Therapeutics Ltd went into administration on 23 September 2024.
Report an error on this page·Not financial, credit or legal advice.